Partnership news in the works. Like i said Teva made a bad decision to drop RX-3117. Current therapy for solid tumors is metabolite which is toxic. RX-3117 has already proven itself in multiple cancer compounds. LIke I said a new partner will immediately step up and partner with the company for that drug.